WT1 overexpression: A clinically useful marker in acute and chronic myeloid leukemias

Hematology

Volumn 10, Issue SUPPL. 1, 2005, Pages 76-78

  Saglio, Giuseppe ^a   Carturan, Sonia ^a   Grillo, Sara ^a   Capella, Sara ^a   Arruga, Francesca ^a   Defilippi, Ilaria ^a   Rosso, Valentina ^a   Rauco, Maria ^b   Liberati, Anna Marina ^b   Cilloni, Daniela ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; WT1 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; CHEMOTHERAPY; CHRONIC MYELOID LEUKEMIA; FUSION GENE; GENE REARRANGEMENT; HUMAN; MINIMAL RESIDUAL DISEASE; MYELOID LEUKEMIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY;

ACUTE DISEASE; BIOLOGICAL MARKERS; CHRONIC DISEASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, WILMS TUMOR; HUMANS; LEUKEMIA, MYELOID; PREDICTIVE VALUE OF TESTS; RECURRENCE;

EID: 29244451398     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330512331390005     Document Type: Short Survey

References (11)

1. Call KM, Glaser T, Ito CY, Buckler A, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' Tumor Locus. Cell 1990;60:509-520.
2. Park S, Schalling M, Bernard A, Maheswaran S, Shipley GC, Roberts D, Fletcher J, Schpman R, RheinWald J, Demetri G. The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nature Genetics 1993;4:415-420.
3. Menssen HD, Renkl HJ, Rodeck U, Maurer J, Nutter M, Schwartz S, Reinhardt R, Thiel E. Presence of Wilms' tumor gene (WT1) transcripts and WT1 nuclear protein in the majority of human acute leukemias. Leukemia 1995;9:1060-1067.
4. Miwa H, Beran M, Saunders GF. Expression of the wilms' tumor gene (WT1) in hman leukemias. Leukemia 1992;6:405-409.
5. Inoue K, Ogawa H, Sonoda Y, Kimura T, Sakabe H, Oka Y, Miyake S, Tamaki H, Oji Y, Yamagami T, et al. Aberrant overexpression of the Wilms Tumor Gene (WT1) in human leukemia. Blood 1997;89:1405-1412.
6. Cilloni D, Gottardi E, De Micheli D, Serra A, Volpe G, Messa F, Rege-Cambrin G, Guerrasio A, Divona M, Lo Coco F, Saglio G. Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients. Leukemia 2002;16:2115-2121.
7. Gaiger A, Schmid D, Heinze G, Linnerth B, Greinix H, Halhs P, Tisljar K, Prigljnger S, Mitterbauer M, Novak M, et al. Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia. Leukemia 1998;12:1886-1894.
8. Inoue K, Tamaki H, Ogawa H, Oka Y, Soma T, Tatekawa T, Oji Y, Tsuboi A, Kim EH, Kawakami M, et al. Wilms' tumor gene (WT1) competes with differentiation -inducing signal in hematopoietic progenitor cells. Blood 1998;91:2969-2976.
9. Maurer U, Weidmann E, Karakas T, Hoelzer D, Bergmann L. Wilms Tumor Gene (wt1) mRNA is equally expressed in blast cells from acute myeloid leukemia and normal CD34+ progenitors. Blood 1997;90:4230-4232.
10. Cilloni D, Gottardi E, Messa F, Fava M, Scaravaglio P, Bertini M, Girotto M, Marinone C, Ferrero D, Gallamini A, et al. Very significant correlation between the degree of WT1 expression and the IPSS score in patients affected by myelodysplastic syndromes. (submitted)
11. Inoue K, Ogawa H, Yamagami T, Soma T, Tani Y, Tatekawa T, Oji Y, Tamaki H, Kyo T, Dohy H, et al. Log-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels. Blood 1996;88:2267-2278.